Send the following on WhatsApp
Continue to ChatComparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen - https://avesis.gazi.edu.tr/yayin/6fe2a379-314d-4d68-aa16-64f5cc266c0d/comparison-the-efficacy-of-second-line-modified-eox-epirubicin-oxaliplatin-and-capecitabine-and-irinotecan-5-fluorouracil-and-leucovorin-folfiri-regimens-in-metastatic-gastric-cancer-patients-that-progressed-on-first-line-modified-docetaxel-and-cispl